Ellis Investment Partners, LLC Moderna, Inc. Transaction History

Ellis Investment Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 03, 2022	BUY	$126.46 - $235.05 $28,453 - $52,886	225 Added 112.5%	425 $73,000
Q4 2021 Feb 01, 2022	BUY	$225.82 - $368.51 $45,164 - $73,702	200 New	200 $50,000
Q3 2021 Oct 21, 2021	SELL	$221.9 - $484.47 $2,219 - $4,844	-10 Closed	0 $0
Q2 2021 Jul 26, 2021	SELL	$129.91 - $234.98 $5,196 - $9,399	-40 Reduced 80.0%	10 $2,000
Q4 2020 Jan 20, 2021	SELL	$65.74 - $169.86 $6,573 - $16,986	-100 Reduced 66.67%	50 $5,000
Q3 2020 Oct 19, 2020	SELL	$54.34 - $94.85 $271 - $474	-5 Reduced 3.23%	150 $10,000
Q2 2020 Jul 13, 2020	BUY	$29.67 - $80.0 $3,115 - $8,400	105 Added 210.0%	155 $9,000
Q1 2020 Apr 17, 2020	BUY	$17.78 - $31.58 $889 - $1,579	50 New	50 $1,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Ellis Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Ellis Investment Partners, LLC with notifications on news.